%0 Journal Article
%T The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients
%A Edoardo Benedetti
%A Elena Ciabatti
%A Elisa Mazzantini
%A Enrico Orciuolo
%A Federica Ricci
%A Francesca Guerrini
%A Francesca Martini
%A Francesco Caracciolo
%A Francesco Mazziotta
%A Gabriele Buda
%A Giovanni Carulli
%A Giovanni Consani
%A Lorenzo Iovino
%A Maria Rita Metelli
%A Mario Petrini
%A Matteo Pelosini
%A Pietro Rossi
%A Rita Tavarozzi
%A Sara Galimberti
%A Serena Salehzadeh
%A Susanna Grassi
%A Umberto Pizzano
%J Archive of "Cancer Cell International".
%D 2019
%R 10.1186/s12935-019-0807-0
%X The online version of this article (10.1186/s12935-019-0807-0) contains supplementary material, which is available to authorized users
%K AML
%K FLT3
%K NPM1
%K WT1
%K ASXL1
%K TP53
%K IDH
%K RUNX1
%K Additional mutations
%K AML outcome
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449954/